6 and associated risk factors—United States, 1999–2004,” Mor- bidity and Mortality Weekly Report, vol. 56, no. 8, pp. 161–165, 2007. [28] K. L. Ong, B. M. Y. Cheung, Y. B. Man, C. P. Lau, and K. S. L. Lam, “Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004,” Hypertension, vol. 49, no. 1, pp. 69–75, 2007. [29] J. Moore, “Hypertension: catching the silent killer,” The Nurse Practitioner, vol. 30, no. 10, pp. 16–18, 2005. [30] N. Mumoli and M. Cei, “Licorice-induced hypokalemia,” International Journal of Cardiology, vol. 124, no. 3, pp. e42– e44, 2008. [31] S. H. van Uum, “Liquorice and hypertension,” The Nether- lands Journal of Medicine, vol. 63, no. 4, pp. 119–120, 2005. [32] S. Russo, M. Mastropasqua, M. A. Mosetti, C. Persegani, and A. Paggi, “Low doses of liquorice can induce hypertension encephalopathy,” American Journal of Nephrology, vol. 20, no. 2, pp. 145–148, 2000. [33] T. Saito, Y. Tsuboi, G. Fujisawa, et al., “An autopsy case of licorice-induced hypokalemic rhabdomyolysis associated with acute renal failure: special reference to profound calcium deposition in skeletal and cardiac muscle,” Nippon Jinzo Gakkai Shi, vol. 36, no. 11, pp. 1308–1314, 1994. [34] T. Breidthardt, M. Namdar, and B. Hess, “A hypertensive urgency induced by the continuous intake of a herbal remedy containing liquorice,” Journal of Human Hypertension, vol. 20, no. 6, pp. 465–466, 2006. [35] G. J. de Klerk, M. G. Nieuwenhuis, and J. J. Beutler, “Hypokalaemia and hypertension associated with use of liquorice ﬂavoured chewing gum,” British Medical Journal, vol. 314, no. 7082, pp. 731–732, 1997. [36] R. G. Dluhy, B. Anderson, B. Harlin, J. Ingelﬁnger, and R. Lifton, “Glucocorticoid-remediable aldosteronism is associ- ated with severe hypertension in early childhood,” Journal of Pediatrics, vol. 138, no. 5, pp. 715–720, 2001. [37] R. P. Lifton, “Genetic dissection of human blood pressure variation: common pathways from rare phenotypes,” Harvey Lectures, vol. 100, pp. 71–101, 2004. [38] D. Armanini, L. Calo` , and A. Semplicini, “Pseudohyperal- dosteronism: pathogenetic mechanisms,” Critical Reviews in Clinical Laboratory Sciences, vol. 40, no. 3, pp. 295–335, 2003. [39] B. Sontia, J. Mooney, L. Gaudet, and R. M. Touyz, “Pseudohy- peraldosteronism, liquorice, and hypertension,” The Journal of Clinical Hypertension, vol. 10, no. 2, pp. 1–5, 2008. [40] L. Z. G. Touyz, “Liquorice, hypertension and the dentist,” The Journal of the Canadian Dental Association, vol. 73, no. 6, pp. 467–468, 2007. [41] J. Vaya, P. A. Belinky, and M. Aviram, “Antioxidant con- stituents from liquorice roots: structure elucidation and anti-oxidative capacity towards LDL oxidation,” Free Radical Biology & Medicine, vol. 23, no. 2, pp. 302–313, 1997. Case Reports in Medicine